首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1746491

日本蛋白質體學市場報告（按分析類型、組件類型、技術、應用、最終用戶（臨床診斷實驗室、研究機構等）和地區）2025-2033

Japan Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 120 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本蛋白質體學市場規模達26億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到116億美元，2025-2033年期間的複合年成長率（CAGR）為16.7%。政府機構對新藥研發的投入不斷增加，是推動市場成長的主要動力。

蛋白質體學是對蛋白質進行全面研究的學科，涵蓋其結構和功能。它深入研究蛋白質在不同環境下的變化和適應方式。該領域研究蛋白質在功能和非功能狀態下的存在和結構，旨在揭示其特定作用及其與其他蛋白質的相互作用。為了實現這一目標，人們結合蛋白質體學，運用一系列先進技術來精確定位和定量蛋白質，並識別潛在的診斷指標。此外，蛋白質體學還能評估蛋白質的生成速度並繪製其交互作用網路。鑑於這些能力，蛋白質體學在推進藥物研究和根據個體需求定製藥物方面發揮著至關重要的作用。

日本蛋白質體學市場趨勢：

在日本市場，對個人化醫療日益成長的需求正顯著推動市場成長。生物技術和藥物研發的持續進步也進一步推動了這一成長。蛋白質體學系統的應用簡化了藥物研發流程，成為多種藥物化學配方和生物學評估不可或缺的一部分。此外，日本的尖端技術和強大的研發基礎設施使得蛋白質的細緻分析成為可能。這種細緻的分析在癌症治療方案的發展中發揮關鍵作用，是市場成長的重要因素。日本醫療體系的完善，加上政府支持新藥研發和研究的政策，進一步鞏固了這個市場上升趨勢。此外，精細蛋白質分析方法中技術日益融合也推動了市場的發展。這些方法涵蓋電噴霧電離-液相層析質譜法 (ESI-LC-MS)、表面等離子體共振、微陣列、蛋白質分餾系統和X光晶體學等技術。這些創新有助於對蛋白質進行深入的定量和定性檢測，有助於確定癌症治療方法。此外，政府機構推出的促進廣泛研發活動的法規預計將在未來幾年推動區域市場的發展。

日本蛋白質體學市場細分：

分析類型洞察：

結構蛋白質體學
功能蛋白質體學
蛋白質表現蛋白質體學

組件類型洞察：

核心蛋白質體學服務
生物資訊軟體及相關服務

技術洞察：

光譜學
色譜法
電泳
蛋白質微陣列
X光晶體學
表面等離子體共振
其他

應用程式洞察：

蛋白質表現譜
蛋白質體挖掘
轉譯後修飾

最終用戶洞察：

臨床診斷實驗室
研究機構（藥物研發）
其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭指標和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本蛋白質體學市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本蛋白質體學市場有何影響？
根據分析類型，日本蛋白質體學市場是如何分類的？
日本蛋白質體學市場根據組件類型如何分類？
日本蛋白質體學市場按技術分類的分佈是怎麼樣的？
日本蛋白質體學市場根據應用如何分類？
根據最終用戶，日本蛋白質體學市場是如何分類的？
日本蛋白質體學市場的價值鏈分為哪些階段？
日本蛋白質體學的主要促進因素和挑戰是什麼？
日本蛋白質體學市場的結構是怎麼樣的？主要參與者是誰？
日本蛋白質體學市場的競爭程度如何？

本報告回答的關鍵問題：

日本蛋白質體學市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本蛋白質體學市場有何影響？
根據分析類型，日本蛋白質體學市場是如何分類的？
日本蛋白質體學市場根據組件類型如何分類？
日本蛋白質體學市場按技術分類的分佈是怎麼樣的？
日本蛋白質體學市場根據應用如何分類？
根據最終用戶，日本蛋白質體學市場是如何分類的？
日本蛋白質體學市場的價值鏈分為哪些階段？
日本蛋白質體學的主要促進因素和挑戰是什麼？
日本蛋白質體學市場的結構是怎麼樣的？主要參與者是誰？
日本蛋白質體學市場的競爭程度如何？

Japan proteomics market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.6 Billion by 2033, exhibiting a growth rate (CAGR) of 16.7% during 2025-2033. The increasing investments by government bodies in the development of novel drugs are primarily driving the market growth.

Proteomics is the comprehensive study of proteins, encompassing their structures and functions. It delves into how proteins change and adapt under different circumstances. The field investigates the presence and configurations of proteins in both their functional and non-functional states, aiming to discern their specific roles and interactions with other proteins. To achieve this, a range of sophisticated technologies are employed in tandem with proteomics to pinpoint and quantify proteins, as well as to identify potential diagnostic indicators. Additionally, proteomics evaluates the pace at which proteins are produced and maps out their interaction networks. Given these capabilities, proteomics plays a crucial role in advancing drug research and tailoring medicines to individual needs.

Japan Proteomics Market Trends:

In the context of the Japan market, the increasing inclination towards personalized medicine is significantly propelling market growth. This surge is complemented by consistent advancements in biotechnology and drug discovery. Proteomic systems, when implemented, streamline the drug discovery process, becoming integral to the chemical formulation and biological evaluation of multiple medicines. Additionally, Japan's cutting-edge technology and robust research and development (R&D) infrastructure have enabled a nuanced analysis of proteins. This detailed analysis plays a pivotal role in devising cancer treatments, marking a substantial growth factor for the market. The enhancement of Japan's healthcare framework, combined with supportive government policies advocating for research and the discovery of new drugs, further bolsters this upward market trend. Moreover, the market is propelled by the growing integration of technology in detailed protein analysis methods. These methods encompass techniques like Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems, and X-ray crystallography. Such innovations facilitate an in-depth quantitative and qualitative examination of proteins, aiding in the determination of cancer treatments. Furthermore, regulations by government bodies that promote widespread research and development (R&D) activities are expected to fuel the regional market in the coming years.

Japan Proteomics Market Segmentation:

Analysis Type Insights:

Structural Proteomics
Functional Proteomics
Protein Expression Proteomics

Component Type Insights:

Core Proteomics Services
Bioinformatics Software and Related Services

Technology Insights:

Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Surface Plasmon Resonance
Others

Application Insights:

Protein Expression Profiling
Proteome Mining
Post-Translational Modifications

End User Insights:

Clinical Diagnostic Laboratories
Research Organizations (Drug Discovery)
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan proteomics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan proteomics market?
What is the breakup of the Japan proteomics market on the basis of analysis type?
What is the breakup of the Japan proteomics market on the basis of component type?
What is the breakup of the Japan proteomics market on the basis of technology?
What is the breakup of the Japan proteomics market on the basis of application?
What is the breakup of the Japan proteomics market on the basis of end user?
What are the various stages in the value chain of the Japan proteomics market?
What are the key driving factors and challenges in the Japan proteomics?
What is the structure of the Japan proteomics market and who are the key players?
What is the degree of competition in the Japan proteomics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Proteomics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Proteomics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Proteomics Market - Breakup by Analysis Type

6.1 Structural Proteomics
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Functional Proteomics
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Protein Expression Proteomics
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Proteomics Market - Breakup by Component Type

7.1 Core Proteomics Services
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Bioinformatics Software and Related Services
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Proteomics Market - Breakup by Technology

8.1 Spectroscopy
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Chromatography
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Electrophoresis
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Protein Microarrays
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 X-Ray Crystallography
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2019-2024)
- 8.5.3 Market Forecast (2025-2033)
8.6 Surface Plasmon Resonance
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2019-2024)
- 8.6.3 Market Forecast (2025-2033)
8.7 Others
- 8.7.1 Historical and Current Market Trends (2019-2024)
- 8.7.2 Market Forecast (2025-2033)

9 Japan Proteomics Market - Breakup by Application

9.1 Protein Expression Profiling
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Proteome Mining
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Post-Translational Modifications
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)

10 Japan Proteomics Market - Breakup by End User

10.1 Clinical Diagnostic Laboratories
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Research Organizations (Drug Discovery)
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Others
- 10.3.1 Historical and Current Market Trends (2019-2024)
- 10.3.2 Market Forecast (2025-2033)

11 Japan Proteomics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Proteomics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis